Pronađeno: 1-7 / 7 radova

Autori: Giraldo Pilar

>> Prikaži sve rezultate

Naslov Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease (Article)
Autori Zimran Ari  Duran Gloria  Giraldo Pilar  Rosenbaum Hanna  Giona Fiorina  Petakov Milan S  Terreros Munoz Eduardo  Eduardo Solorio-Meza Sergio  Cooper Peter A  Varughese Sheeba  Alon Sari  Chertkoff Raul 
Info BLOOD CELLS MOLECULES AND DISEASES, (2019), vol. 78 br. , str. 14-21
Projekat Protalix BioTherapeutics; Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase (Article)
Autori Zimran Ari  Gonzalez-Rodriguez Derlis Emilio  Abrahamov Aya  Cooper Peter A  Varughese Sheeba  Giraldo Pilar  Petakov Milan S  Tan Ee Shien  Chertkoff Raul 
Info BLOOD CELLS MOLECULES AND DISEASES, (2018), vol. 68 br. , str. 163-172
Projekat Protalix BioTherapeutics; Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M  Shankar Suma P  Petakov Milan S  Giraldo Pilar  Rosenbaum Hanna  Amato Dominick J  Szer Jeffrey  Chertkoff Raul  Brill-Almon Einat  Zimran Ari 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 661-665
Projekat Protalix BioTherapeutics; Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease (Article)
Autori Zimran Ari  Duran Gloria  Mehta Atul  Giraldo Pilar  Rosenbaum Hanna  Giona Fiorina  Amato Dominick J  Petakov Milan S  Munoz Eduardo Terreros  Solorio-Meza Sergio Eduardo  Cooper Peter A  Varughese Sheeba  Chertkoff Raul  Brill-Almon Einat 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 656-660
Projekat Protalix BioTherapeutics; Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M  Petakov Milan S  Giraldo Pilar  Rosenbaum Hanna  Szer Jeffrey  Deegan Patrick B  Amato Dominick J  Mengel Eugen  Tan Ee Shien  Chertkoff Raul  Brill-Almon Einat  Zimran Ari 
Info BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260
Projekat Protalix BioTherapeutics; Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov The cognitive profile of type 1 Gaucher disease patients (Article)
Autori Biegstraaten Marieke  Wesnes Keith A  Luzy Cecile  Petakov Milan S  Mrsic Mirando  Niederau Claus  Giraldo Pilar  Hughes Derralyn  Mehta Atul  Mengel Karl-Eugen  Hollak Carla EM  Marodi Laszlo  van Schaik Ivo N 
Info JOURNAL OF INHERITED METABOLIC DISEASE, (2012), vol. 35 br. 6, str. 1093-1099
Projekat Actelion [TAMOP 4.2.1./B-09/1/KONV-2010-0007, TAMOP 4.2.2-08/1-2008-0015]; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland; European Working Group on Gaucher Disease (EWGGD)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study (Article)
Autori Biegstraaten Marieke  Mengel Eugen  Marodi Laszlo  Petakov Milan S  Niederau Claus  Giraldo Pilar  Hughes Derralyn  Mrsic Mirando  Mehta Atul  Hollak Carla EM  van Schaik Ivo N 
Info BRAIN, (2010), vol. 133 br. , str. 2909-2919
Projekat European Working Group on Gaucher Disease (EWGGD) ; Actelion Pharmaceuticals Ltd ; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX